Patent: 9,750,713
✉ Email this page to a colleague
Summary for Patent: 9,750,713
| Title: | Compositions and methods of use of phorbol esters |
| Abstract: | Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson\'s disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects. |
| Inventor(s): | Chen; Hung-Fong (Taipei, TW), Han; Zheng Tao (Zhengzhou, CN) |
| Assignee: | Biosuccess Biotech Co. Ltd. (Santa Clara, CA) |
| Application Number: | 15/154,100 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,750,713
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Swedish Orphan Biovitrum Ab (publ) | KEPIVANCE | palifermin | For Injection | 125103 | 12/15/2004 | ⤷ Try a Trial | 2027-01-31 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
